Molecule Details
| InChIKey | UBCHPRBFMUDMNC-UHFFFAOYSA-N |
|---|---|
| Compound Name | Rimantadine |
| Canonical SMILES | CC(N)C12CC3CC(CC(C3)C1)C2 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.28 |
| Source | BindingDB;ChEMBL |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB00478 |
|---|---|
| Drug Name | Rimantadine |
| CAS Number | 13392-28-4 |
| Groups | approved |
| ATC Codes | J05AC02 |
| Description | An RNA synthesis inhibitor that is used as an antiviral agent in the prophylaxis and treatment of influenza. |
Categories: Adamantanes Anti-Infective Agents Antiinfectives for Systemic Use Antiviral Agents Bridged-Ring Compounds Cyclic Amines Cycloparaffins Enzyme Inhibitors Influenza A M2 Protein Inhibitor M2 Protein Inhibitors Nucleic Acid Synthesis Inhibitors
Cross-references: BindingDB: 50216627 ChEBI: 94440 CHEMBL959 ChemSpider: 4893 C07236 D08483 PharmGKB: PA164748038 PubChem:5071 PubChem:46505973 RxCUI: 9386 Therapeutic Targets Database: DAP001087 Wikipedia: Rimantadine
Target Activities (2)
DrugBank Target Actions (1)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| P21430 | P21430 | Matrix protein 2 | other/unknown | targets |